Daclizumab Subcutaneous and Targretin topical

• Generic Name: daclizumab
• Dosage Forms: n.a.
• Other Brand Names: Zinbryta, Zenapax

Daclizumab injection is used to treat the relapsing forms of multiple sclerosis (MS). Daclizumab will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease. It should only be used when other medicines to treat MS did not work well.

Daclizumab was available only under a restricted distribution program called the Zinbryta® REMS (Risk Evaluation and Mitigation Strategy) Program.

Daclizumab was voluntarily withdrawn from the worldwide market on March 2, 2018 due to safety concerns.

• Generic Name: bexarotene topical
• Dosage Forms: gel
• Other Brand Names: Targretin topical

Targretin is a cancer medication that interferes with the growth and spread of cancer cells in the body.

Targretin (for the skin) is used to treat skin lesions caused by cutaneous T-cell lymphoma (CTCL). This medicine is usually given after other cancer medications have been tried without successful treatment.

Targretin may also be used for purposes not listed in this medication guide.